Plasma triglycerides as a risk factor for chronic kidney disease in type 2 diabetes mellitus: Evidence from northeastern Thailand

Published:February 12, 2018DOI:


      • Increased plasma triglyceride was associated with a higher risk of CKD among the Thai diabetic population.
      • Study findings suggest to incorporate triglyceride monitoring in routine clinical practices.
      • High TG level could guide physicians to institute early preventive measures to slow CKD progression.



      To investigate the observational association between plasma triglyceride and CKD in patients with T2DM.


      A hospital-based retrospective registry was used to obtain data of 3,748 T2DM patients from May 2016 to October 2016. Anthropometric measurements and biochemical reports of T2DM patients with CKD were obtained by data extraction of medical records. CKD was defined according to the estimated glomerular filtration rate (eGFR< 60 mL/min/1.73 m2). Multiple logistic regression was used to determine the association between plasma triglyceride and CKD.


      The mean age of the participants was 61.4 ± 11.0 years, and a majority of them was female (64%) with poor glycemic control (83%), increased plasma triglyceride (51%) and 27% of T2DM patients had CKD. There was a significant trend towards deteriorating renal function (lower eGFR) with categorically raised triglyceride levels. After controlling for age, sex and other confounders, ‘borderline high’ (adjusted odds ratio (OR): 1.24, 95% confidence interval (CI): 1.01–1.54), ‘high’ (adjusted OR: 1.52, 95% CI: 1.24–1.85) and ‘very high’ (adjusted OR: 3.40, 95% CI: 1.94–5.94) triglyceride level groups had higher likelihood to have CKD compared to normal triglyceride level.


      CKD was associated with a higher level of plasma triglyceride among patients with T2DM. These results support the rationale to screen and manage increased triglyceride in routine clinical practices among persons with diabetes to prevent CKD.


      CKD (Chronic kidney disease), TG (Triglyceride), AOR (Adjusted odds ratio), COR (Crude odds ratio), MDRD-4 (Modification of diet in renal disease 4 variables), HbA1c (Glycated haemoglobin), LDL-C (Low density lipoprotein cholesterol), WHO (World Health Organization), NKF-KDOQI (National Kidney Disease Outcomes Quality Initiative), eGFR (estimated Glomerular Filtration Rate)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Diabetes, Springer; 2013. p. 42–50. .

        • Bhutani J.
        • Bhutani S.
        Worldwide burden of diabetes.
        Indian J Endocrinol Metab. 2014; 18: 868
        • Eiam-Ong S.
        • Sitprija V.
        Comorbidities in patients with end-stage renal disease in developing countries.
        Artif Organs. 2002; 26: 753-756
        • Beulens J.W.
        • Grobbee D.E.
        • Nealb B.
        The global burden of diabetes and its complications: an emerging pandemic.
        Eur J Cardiovas Prevent Rehab. 2010; 17: s3-s8
        • Ingsathit A.
        • Thakkinstian A.
        • Chaiprasert A.
        • Sangthawan P.
        • Gojaseni P.
        • Kiattisunthorn K.
        • et al.
        Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study.
        Nephrol Dial Transplant. 2010; 25: 1567-1575
      2. Narenpitak S, Narenpitak A. Prevalence of chronic kidney disease in type 2 diabetes in primary health care unit of Udon Thani province, Thailand. Med J Med Assoc Thailand. 2008; 91(10): 1505.

        • Zaman S.B.
        • Hossain N.
        • Rahman A.E.
        • Islam S.M.
        Can glycated hemoglobin act as a reliable glycemic indicator in patients with diabetic chronic kidney disease? evidence from the Northeast of Thailand.
        Med J Indonesia. 2017; 26: 102-108
        • Sakthong P.
        • Kasemsup V.
        Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis.
        Value in Health. 2012; 15: S79-S84
        • Zaman S.B.
        Detection of chronic kidney disease by using different equations of glomerular filtration rate in patients with type 2 diabetes mellitus: a cross-sectional analysis.
        Cureus. 2017; 9: e1352
      3. Nitiyanant W, Chetthakul T, Sang-A-kad P, Therakiatkumjorn C, Kunsuikmengrai K, Yeo JP. A survey study on diabetes management and complication status in primary care setting in Thailand. J Med Assoc of Thailand. 2007;90(1):65.

        • Muktabhant B.
        • Sanchaisuriya P.
        • Sarakarn P.
        • Tawityanon W.
        • Trakulwong M.
        • Worawat S.
        • et al.
        Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.
        BMC Public Health. 2012; 12: 1
      4. Kyrou I, Randeva HS, Weickert MO. Clinical problems caused by obesity. 2014.

        • Pongchaiyakul C.
        • Pratipanawatr T.
        Prevalence of dyslipidemia in rural Thai adults: an epidemiologic study in Khon Kaen province.
        J Med Assoc Thai. 2005; 88: 1092-1097
        • Cullen P.
        Evidence that triglycerides are an independent coronary heart disease risk factor.
        Am J Cardiol. 2000; 86: 943-949
      5. Cullen P. Triacylglycerol-rich lipoproteins and atherosclerosis– where is the link?: Portland Press Limited; 2003. .

        • Tsimihodimos V.
        • Dounousi E.
        • Siamopoulos K.C.
        Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment.
        Am J Nephrol. 2008; 28: 958-973
        • Kasiske B.L.
        • O'donnell M.P.
        • Cleary M.P.
        • Keane W.F.
        Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats.
        Kidney Int. 1988; 33: 667-672
      6. World Health Organization. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. 2011. [accessed: 20 June, 2017]

        • Jellinger P.
        • Smith D.
        • Mehta A.
        • Ganda O.
        • Handelsman Y.
        • Rodbard H.
        • et al.
        American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis.
        Endocrine Pract. 2012;
        • Levey A.S.
        • Coresh J.
        • Balk E.
        • Kausz A.T.
        • Levin A.
        • Steffes M.W.
        • et al.
        National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
        Ann Intern Med. 2003; 139: 137-147
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • Zhang Y.L.
        • Castro A.F.
        • Feldman H.I.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
        • Hsu C.
        • Bansal N.
        Measured GFR as “gold standard”—all that glitters is not gold?.
        Clin J Am Soc Nephrol. 2011; 6: 1813-1814
        • Domrongkitchaiporn S.
        • Sritara P.
        • Kitiyakara C.
        • Stitchantrakul W.
        • Krittaphol V.
        • Lolekha P.
        • et al.
        Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study.
        J Am Soc Nephrol. 2005; 16: 791-799
      7. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP. 2013 [Available from:].

        • Jha V.
        End-stage renal care in developing countries: The India Experience.
        Ren Fail. 2004; 26: 201-208
        • Abbagani S.
        • Gundimeda S.D.
        • Varre S.
        • Ponnala D.
        • Mundluru H.P.
        Kidney stone disease: etiology and evaluation.
        Int J Appl Biol Pharma Technol. 2010; 1: 175-182
        • Srivanichakorn S.
        • Sukpordee N.
        • Yana T.
        • Sachchaisuriya P.
        • Schelp F.P.
        Health status of diabetes type 2 patients in Thailand contradicts their perception and admitted compliance.
        Primary Care Diabetes. 2011; 5: 195-201
        • Rifkin D.E.
        • Shlipak M.G.
        • Katz R.
        • Fried L.F.
        • Siscovick D.
        • Chonchol M.
        • et al.
        Rapid kidney function decline and mortality risk in older adults.
        Arch Intern Med. 2008; 168: 2212-2218
        • Lee P.-H.
        • Chang H.-Y.
        • Hsu Y.-C.
        • Lei C.-C.
        • Chang H.-H.
        • Tung C.-W.
        • et al.
        Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults.
        Am J Med Sci. 2009; 338: 185-189
        • Hadjadj S.
        • Duly-Bouhanick B.
        • Bekherraz A.
        • Br Idoux F.
        • Gallois Y.
        • Mauco G.
        • et al.
        Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
        Diabetes Metab. 2004; 30: 43-51
        • Tan K.
        • Betteridge D.
        • Marmot M.
        • Talmud P.
        • Humphries S.
        • Yudkin J.
        Hypertriglyceridaemia and vascular risk: report of a Meeting of Physicians and Scientists, University College London Medical School.
        Lancet. 1993; 342: 781-787
        • McNamara J.
        • Campos H.
        • Ordovas J.
        • Peterson J.
        • Wilson P.
        • Schaefer E.
        Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.
        Arterioscler Thromb Vasc Biol. 1987; 7: 483-490
        • Losada M.
        • Alio J.
        Malondialdehyde serum concentration in type 1 diabetic with and without retinopaty.
        Doc Ophthalmol. 1997; 93: 223-229
        • Ding G.
        • Van Goor H.
        • Ricardo S.D.
        • Orlowski J.M.
        • Diamond J.R.
        Oxidized LDL stimulates the expression of TGF-β and fibronectin in human glomerular epithelial cells.
        Kidney Int. 1997; 51: 147-154
        • Blankestijn P.
        Effects of eprosartan in chronic kidney disease.
        J Clin Basic Cardiol. 2006; 8: 15-17
        • Jeenduang N.
        • Whanmasae S.
        • Seepawin P.
        • Kullabootr S.
        The prevalence of dyslipidemia among a rural Thai population in the Nakhon Si Thammarat province.
        J Med Assoc Thai. 2013; 96: 992-1000